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Monoclonal antibody (Mab) 11D1 specific for HHV-8 showed a predominantly nuclear membrane fluorescence with about
30% of phorbol ester (TPA)-induced HHV-8-carrying BCBL-1 cells and with 2–8% of uninduced cells, but not with other herpes
viruses infected cells. This Mab immunoprecipitated a 50-kDa polypeptide from BCBL-1 cells. The synthesis of this
polypeptide was reduced but not inhibited by phosphonoacetic acid (PAA). A 2.3-kb cDNA insert from a cDNA library of
TPA-induced BCBL-1 cells was identified by Mab 11D1. Sequence analysis shows that this cDNA is open at the 59 end and
encodes two ORFs of 396AA (59 end) and 357AA (39 end). These ORFs are identical to the published HHV-8 ORFs 59 and 58,
respectively. In vitro transcription and translation of the cDNA resulted in the synthesis of a 50-kDa polypeptide and its partial
peptide map was identical to that of the 50-kDa polypeptide detected in the TPA induced BCBL-1 cells. Riboprobe made from
the cDNA insert hybridized with several viral specific RNAs from BCBL-1 cells. Levels of these RNA species were reduced,
but not inhibited by PAA. These characteristics are similar to other herpes viruses genes encoding the lytic cycle associated
early–late class accessory proteins that are essential for viral DNA replication. This Mab 11D1 recognizing the HHV-8 lytic
cycle associated ORF 59 protein will be highly useful in monitoring the lytic replicative cycle. © 1998 Academic Press
INTRODUCTION
Human herpesvirus-8 (HHV-8) or Kaposi’s sarcoma
associated herpesvirus is a newly identified herpesvirus
with a strong association with Kaposi’s sarcoma (KS).
HHV-8 DNA has been detected in over 95% of Kaposi’s
lesions studied, both in HIV2 and HIV1 individuals as
well as in all clinical subtypes of KS (Ambroziak et al.,
1995; Cesarman et al., 1995b; Chang et al., 1994, 1996;
Dupin et al., 1995; Huang et al., 1995; Moore and Chang,
1995; Smith et al., 1997). In addition, HHV-8 sequences
have been detected in body-cavity-based B-cell lympho-
mas (BCBL) and B cell lines (BC-1, HBL-6, and BCBL-1)
have been established from the BCBL tumors (Cesarman
et al., 1995a,b; Gao et al., 1996a,b; Moore et al., 1996a,b;
Renne et al., 1996). BC-1 and HBL-6 carry both HHV-8
and human Epstein–Barr virus (EBV). Upon phorbol ester
(TPA) induction, high levels of EBV were reactivated from
these cells with only a small quantity of HHV-8 DNA
replication (Cesarman et al., 1995a,b; Moore et al.,
1996a,b). BCBL-1 cells carry only HHV-8 and lytic cycle
can be induced by TPA (Lennette et al., 1996; Renne et
al., 1996; Smith et al., 1997). BCBL cells have been used
in immunofluorescence and Western blot assays to mea-
sure antibody responses in human sera (Gao et al.,
1996a,b; Kedes et al., 1996; Lennette et al., 1996; Smith et
al., 1997).
A sequence of about 140 kb HHV-8 DNA encoding 80
complete ORFs has been published very recently (Russo
et al., 1996; Neipel et al., 1997). Phylogenetic analysis of
the HHV-8 genome, the gene arrangements, and protein
sequences deduced from these sequences show strik-
ing similarity to herpesvirus saimiri, a simian herpesvi-
rus, and slightly more distantly related to EBV; both
viruses are in the gammaherpesvirus group (Albrecht et
al., 1992; Kieff et al., 1996; Russo et al., 1996; Neipel et al.,
1997). These HHV-8 ORFs are currently identified as
ORFs 4 to 75 by their similarity to HVS ORFs. HHV-8 also
encodes 19 unique ORFs which are designated K1 to K15
(Russo et al., 1996; Neipel et al., 1997). Identification and
characterization of HHV-8 proteins are fundamental to a
rational understanding of the biology of HHV-8 and its
role in KS or other human diseases and for diagnostic
purposes. As an initial step toward achieving these
goals, we have developed monoclonal antibodies
against TPA-induced BCBL-1 cells. In this report, we
describe the characterization of a 50-kDa protein of
HHV-8 associated with the lytic replicative cycle.
MATERIALS AND METHODS
Cell lines
HHV-8-positive and EBV-negative body cavity B cell
lymphoma cell line BCBL-1 (Renne et al., 1996), HHV-81
and EBV1 HBL-6 cells (Moore et al., 1996a,b), EBV-
producer cell line P3HR-1, and EBV-negative B cell line
BJAB were grown in RPMI 1640 medium with glutaMAX I
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(Gibco-BRL) supplemented with 10% heat-inactivated fe-
tal bovine serum and antibiotics. The BCBL-1 cells were
a gift from Dr. McGrath (UCLA) and the HBL-6 cells were
a gift from Dr. P. Moore (Columbia University, NY). Single
cell clones from HBL-6 cells (HHV-81, EBV1) were es-
tablished by limiting dilutions and were tested by PCR for
HHV-8 and EBV DNA using primers described as before
(Smith et al., 1997) and by IFA for EBV and HHV-8 using
human sera (Smith et al., 1997). Three types of clones
were obtained: HHV-81, EBV1; HHV-8-negative, EBV1;
and HHV-8-negative, EBV-negative. These were recloned
and retested. These B cell lines designated D6 and C6
(HHV-8-negative and EBV-negative) and E5 (HHV-8-neg-
ative and EBV- positive) were used as controls for the
experiments described here.
Immunofluorescence assay (IFA)
IFA was performed as per procedures described be-
fore (Smith et al., 1997). Briefly, 107 cells in 10 ml medium
were induced with 20 ng/ml of TPA (Sigma, St. Louis,
MO). Uninduced and TPA-induced BCBL-1 cells, TPA-
induced P3HR-1 cells, and TPA-induced BJAB cells were
collected, washed in phosphate buffered saline, pH 7.4
(PBS), spotted on slides (5-mm inner diameters, 10 cir-
cles per slide), air dried in a laminar flow hood under UV
light, and fixed in cold acetone for 10 min. Fixed cells
were incubated for 30 min at 37°C with 1:2 dilution of
monoclonal antibody (Mab) 11D1. After incubation, slides
were washed rigorously in PBS. The slides were then
incubated for 30 min at 37°C with a prestandardized
dilution of fluorescein isothiocyanate-conjugated goat
anti-mouse IgG (Hyclone, Logan, UT). After washing, the
slides were counter stained with 1:20,000 dilution of
Evans blue (Sigma) for 5 min at room temperature,
washed, and mounted with 50% (v/v) glycerol in PBS.
Slides were examined under a fluorescence microscope.
Production and characterization of monoclonal
antibodies
TPA-induced BCBL-1 cells were collected 3 days
postinduction and washed twice with PBS and 1 3 107
cells were injected intraperitoneally into each Balb/c
mouse. After three such injections, spleen cells were
obtained and fused with Sp2/0 myeloma cells as per
procedures described before (Balachandran et al., 1989;
Balachandran, 1992). Hybridoma supernatants were
screened by differential screening in ELISA and IFA. For
ELISA, uninduced and TPA-induced BCBL-1 (HHV-81),
D6 (HHV-82, EBV2), and E5 (HHV-82, EBV1) cells were
used. ELISA was performed as per procedures de-
scribed previously (Balachandran et al., 1989; Balachan-
dran, 1992). IFA with uninduced and TPA-induced BCBL-1
cells, D6, P3HR-1, and BJAB were performed as per
procedures described previously (Smith et al., 1997).
Since host proteins were also present in the immunizing
antigens, clones secreting antibodies reactive only with
BCBL-1 were selected for further testing. These were
further expanded, frozen, and monocloned twice. Mono-
clones were rescreened by the same techniques de-
scribed above. High titer antibodies containing ascitic
fluids were made by injecting hybridoma cells intraperi-
toneally into pristane-treated Balb\c mice. These anti-
bodies were subsequently tested in IFA with EBV pro-
ducer (P3HR-1) cells, nonproducer (Raji) cells, CMV,
HSV-1, HSV-2, and HHV-6.
Radiolabeling, radioimmunoprecipitation (RIP), and
sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE)
A total of 107 uninduced and TPA-induced (72–96 h
postinduction) cells were labeled for 20 h with 250 mCi of
[35S]methionine and cysteine (Tran35S label, 1177 Ci/
mmol; ICN, Irvine, CA). In studies to determine the kinet-
ics of HHV-8 protein synthesis, after TPA induction (time
0), cells were labeled for different lengths of time (0–24,
24–48, 48–72, and 72–96 h postinduction). In studies with
viral DNA synthesis inhibitor, cells were preincubated
with phosphonoacetic acid (300 mg/ml. PAA. Sigma) for
3 h, washed, resuspended in medium with TPA (20 ng/
ml) and PAA (300 mg/ml), and incubated for 24 h with 250
mCi of [35S]methionine and cysteine.
Immunoprecipitation was carried out according to pro-
cedures described previously (Balachandran et al., 1989;
Balachandran, 1992; Chang and Balachandran, 1991;
Pfeiffer et al., 1995; Qian et al., 1993; Smith et al., 1997).
Briefly, cells were solubilized with lysing buffer (0.05 M
Tris–hydrochloride, pH 7.5, 0.15 M NaCl, 1% sodium de-
oxycholate, 1% Triton X-100, 100 U of aprotinin/ml, 0.1 mM
phenylmethylsulfonyl fluoride), sonicated, and centri-
fuged at 100,000g for 1 h. Equal trichloroacetic acid
precipitable counts (5 3 105 cpm) of cell lysates were
mixed with 10 ml of antibodies and 100 ml of protein
A–Sepharose beads (Pharmacia; Piscataway, NJ) and
were kept rocking at 4°C for 2 h. The precipitates were
washed, dissociated by boiling in sample buffer, and
analyzed by SDS–PAGE in 9% acrylamide cross-linked
with 0.28% N,N9-diallyltartardiamide (Sigma). Molecular
weight markers (Sigma) were electrophoresed in parallel
channels. Gels were stained, destained, infused with 1
M salicyclic acid, dried on filter paper, and placed in
contact with XAR-5 film (Kodak; Rochester, NY) at 270°C
for fluorography.
Construction of cDNA library and screening of lZAPII
expression system
Total RNA extracted from TPA-induced BCBL-1 cells
(24, 48, 72, and 96 h postinduction) were treated with
DNase and verified for the absence of HHV-8 DNA by
DNA-PCR using ORFs 25 and 26 primers (Smith et al.,
1997). The mRNA was isolated by oligotex mRNA isola-
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tion kit (Qiagen, Chatsworth, CA) and the purified mRNAs
were used in cDNA synthesis using oligo(dT) linker–
primer containing XhoI site (Stratagene, La Jolla, CA)
according to the manufacturer’s recommendations. Syn-
thesized cDNAs were tested for HHV-8 messages by
PCR for HHV-8 ORFs 22, 25, and 26 using primers de-
scribed previously (Smith et al., 1997). Appropriate size
fragments were detected. The cDNA library was made
according to the manufacturer’s recommendations. After
amplification, this library had a titer of about 4 3 109 PFU
with 99% recombinant phages. This library was screened
with monoclonal antibodies using procedures described
previously (Chang and Balachandran, 1991; Pfeiffer et al.,
1995). Immunoreactive phages were picked and purified
by four subsequent steps of screening. The identified
cDNAs were released into the plasmid forms by in vivo
excision using ExAssist helper phage.
DNA sequence analysis
Clones of the cDNAs (both orientations) were se-
quenced in the Bio-technology center at the University of
Kansas Medical Center. Sequences were analyzed and
compared with the data bank by BLAST program.
Construction of ORF59 plasmid
The ORF 59 from the pCD50 clone was amplified by
PCR using ORF59-A primer, GTG CGT CTA CGG CCG
AAT TCA TGC CTG TGG with EcoRI site, and ORF59-B
primer, CTC ACT GTC GCG GCC GCA CAT GGT GTC
AAA TC with NotI site. Amplified PCR fragments were
purified and ligated into pGEM-T vector (Promega). Ori-
entation was verified by restriction enzyme digestion
with NotI.
In vitro transcription and in vitro translation of cDNA
In vitro transcription of the cDNA insert in the plasmid
was done by linearizing the plasmid with appropriate
restriction enzymes and synthesizing sense and anti-
sense RNA transcripts using T3 and T7 RNA poly-
merases, respectively. In vitro transcription of ORF 59 in
pGEM-T was done using SP6 RNA polymerase. Capping
of RNA at 59 was carried out as per procedures de-
scribed in the Riboprobe transcription system instruction
manual (Promega). RNA samples from in vitro transcrip-
tion experiments were translated in vitro using [35S]me-
thionine and rabbit reticulocyte lysate preparations (Pro-
mega) according to the manufacturer’s recommen-
dations. In vitro translated products were boiled with
sample buffer and equal trichloroacetic precipitable
counts were analyzed by SDS–PAGE.
Cleveland partial proteolysis of proteins
Immunoprecipitated and in vitro translated proteins
were electrophoresed as described above and the un-
fixed gels were dried on a filter paper and polypeptide
bands were located by using X-ray film. Polypeptide
bands were excised, rehydrated, and treated with 10 mg
of V8 protease (Sigma), followed by SDS–PAGE in 15%
acrylamide (Chang and Balachandran, 1991; Qian et al.,
1993). Gels were stained, destained, infused with 1 M
salicyclic acid, dried on filter paper, and placed in con-
tact with XAR-5 film at 270°C for fluorography.
RNA extraction, riboprobe synthesis, and northern
blot hybridization
Total RNA was isolated from uninduced and TPA-
induced BCBL-1 cells and from BJAB cells with and
without PAA treatment as per methods described previ-
ously (Chang and Balachandran, 1991; Pfeiffer et al.,
1995). The RNA samples were analyzed by Northern blot
hybridization with an antisense RNA probe transcribed
from the cDNA insert using the Riboprobe kit (Promega).
Northern blots were performed on nylon membranes
using standard methodology (Chang and Balachandran,
1991; Pfeiffer et al., 1995) with 10 mg of total RNA for each
lane. Blotted membranes were hybridized overnight at
65°C in 5 ml of RNA hybridization buffer (53 Denhardt’s
reagent, 53 SSPE, 0.5% SDS, 50% formamide, 100 mg/ml
of salmon sperm DNA) containing approximately 1 3 107
cpm of radiolabeled in vitro transcribed RNA. After hy-
bridization, membranes were washed as per standard
procedures and exposed to Kodak XAR5 film at 270°C.
The membranes were stripped and then rehybridized
with a glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) riboprobe and with a riboprobe from a cDNA
encoding a HHV-8 glycoprotein (B. Chandran and C.
Bloomer, manuscript in preparation).
Nucleotide sequence accession number
The nucleotide sequence reported here has been de-
posited in the GenBank database and assigned acces-
sion No. AF004714.
RESULTS
Mab 11D1 recognizes a 50-kDa protein specific for
HHV-8-infected cells
TPA has been shown to induce lytic infection in the
BCBL-1 cells (Renne et al., 1996). Human sera from
HIV1KS1 individuals recognized about 30% of TPA-in-
duced BCBL-1 cells in IFA and was presumed to be
reacting with lytic antigens (B. Chandran et al., manu-
script in preparation; Lennette et al., 1996; Smith et al.,
1997). We have reported that human sera recognized at
least 20 polypeptides specific for TPA-induced BCBL-1
cells (Smith et al., 1997). To aid in identifying individual
HHV-8 proteins, we developed monoclonal antibodies.
From a single fusion, we obtained 83 clones with specific
reactivities to uninduced and TPA-induced BCBL-1 cells,
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but not with uninduced, TPA-induced control BCBL cells
(D6) or EBV nonproducer cells. These antibodies exhib-
ited different types of reactivities in IFA with uninduced
and TPA-induced BCBL-1 cells. Here we describe the
characterization of Mab 11D1.
Mab 11D1 showed a predominantly nuclear fluores-
cence which mostly localized near the nuclear mem-
brane and occasional cytoplasmic fluorescence. About
30% of TPA-induced HHV-8-carrying BCBL-1 cells (Figs.
1A–1C) and 2–8% of uninduced BCBL-1 cells (Fig. 1D)
reacted with Mab 11D1. Similar reactivities were seen
with uninduced and TPA-induced HHV-8 and EBV-posi-
tive HBL-6 cell line (Moore et al., 1996a) (data not
shown). The Mab did not react with the surfaces of intact
uninduced and TPA-induced BCBL-1 cells. No reactivity
was seen with acetone-fixed uninduced and TPA-in-
duced HHV-8-negative BCBL-D6 cells, BJAB cells
(HHV-82 and EBV-negative), or cells infected with HSV-1,
HSV-2, CMV, HHV-6, and EBV (data not shown). These
results suggested that Mab 11D1 recognized a protein in
HHV-8-infected BCBL-1 cells and the synthesis of this
protein was induced with TPA.
To identify the protein recognized by Mab 11D1, RIP
was carried out. No specific reaction was seen with
normal mouse serum (Fig. 2A, lanes 1–4). Mab 11D1 did
not react with uninduced and TPA-induced BCBL-D6
(HHV-8-negative) cells (Fig. 2A, lanes 5 and 6). In con-
trast, it recognized a 50-kDa [35S]methionine-labeled
polypeptide from TPA-induced BCBL-1 cells (Fig. 2A, lane
8). Longer exposure also showed the reactivity with a
50-kDa polypeptide from uninduced cells (Fig. 2A, lane
7). No reactivity was seen with [3H]glucosamine-labeled
uninduced and TPA-induced BCBL-1 cells, or with
[35S]methionine-labeled EBV1 P3HR-1 cells (data not
shown). Since this Mab specifically reacted with 20–30%
of TPA-induced BCBL-1 cells, but not with TPA-induced
HHV-8-negative cells (EBV2 and EBV1), it was consid-
ered as most likely recognizing a HHV-8 lytic antigen.
The protein recognized by Mab 11D1 was designated
HHV-8 P50.
HHV-8 P50 is an early–late class protein
To determine the kinetics of HHV-8 P50 recognized by
Mab 11D1, BCBL-1 cells were induced with TPA and
labeled with [35S]methionine between 0 and 24, 24 and
48, 48 and 72, and 72 and 96 hours postinduction (p.i.).
Lysates were used for RIP experiments. Electron micro-
scopic examination of TPA-induced cells at 72 h p.i.
revealed large quantities of enveloped virus particles in
cytoplasmic vacuoles and in extracellular compartments
(data not shown). HHV-8 P50 was readily immunoprecipi-
tated by the Mab 11D1 from TPA-induced BCBL-1 cells
labeled between 0 and 24 h p.i. (Fig. 2B, lane 4) and the
synthesis continued throughout the observation period
of 96 h p.i. (Fig. 2B, lanes 2, 5, and 6). The synthesis of
P50 appeared to be maximal between 24 and 48 h p.i.
FIG. 2. Reactivities of Mab 11D1 in radioimmunoprecipitation reac-
tions. (A) 107 uninduced and TPA-induced (72–96 h postinduction) cells
were labeled for 20 h with [35S]methionine and cysteine. Lysates were
used in RIP reactions with normal mouse serum (lanes 1–4) or with
Mab 11D1 (lanes 5–8). Lanes 1 and 5, uninduced D6 (HHV-8-negative)
cells; lanes 2 and 6, TPA-induced D6 cells; lanes 3 and 7, uninduced
BCBL-1 cells; lanes 4 and 8, TPA-induced BCBL-1 cells. Samples were
analyzed on 9% acrylamide cross-linked with N,N9-diallyltartardiamide.
Standard molecular size markers were included in parallel lanes.
Approximate molecular mass (in kilodaltons) of the polypeptide immu-
noprecipitated by the Mab is indicated. (B) Kinetics of synthesis of
HHV-8 P50 protein recognized by Mab 11D1. HHV-8-negative control
BJAB cells (lane 1) and HHV-8-positive BCBL-cells (lanes 2–6) were
stimulated with TPA and labeled with [35S]methionine for 0–24 (lanes 1
and 4), 24–48 (lane 5), 48–72 (lane 6), and 72–96 (lane 2) h post-TPA
induction. Cells were also preincubated with PAA (300 mg/ml) for 3 h,
washed, and incubated in medium with TPA and PAA for 24 h with
[35S]methionine (lane 3).
FIG. 1. Immunofluorescence reactivity of Mab 11D1 with HHV-8-
carrying BCBL-1 cells. Cells were stimulated with 20 ng/ml of TPA and
were stained with Mab. (A–C) BCBL-1 cells after 24, 48, and 72 h
post-TPA induction, respectively. (D) Uninduced BCBL-1 cells. Antibody
reactivity was predominantly located in the nuclear membranes of
2–8% of uninduced and 25–30% of TPA-induced BCBL-1 cells. N, nu-
cleus; Cyt, cytoplasm. A and B, binucleated cells. Fluorescence in A, C,
and D, exclusively located at the nuclear membrane. B, Mab reactivity
is predominantly localized in the nucleus and some in the cytoplasm.
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(Fig. 2B, lane 5). PAA has been shown to inhibit the
replication of other herpesviruses, presumably by inhib-
iting viral DNA replication (Balachandran, 1992; Chang
and Balachandran, 1991; Kieff, 1996). To determine the
kinetic class of HHV-8 P50, BCBL-1 cells were preincu-
bated with 300 mg/ml of PAA (Sigma) for 3 h, incubated
with TPA and PAA, and labeled between 0 and 24 h p.i. In
the presence of PAA, the amount of radiolabeled HHV-8
P50 polypeptide immunoprecipitated was significantly
reduced but not abolished (Fig. 2B, lane 3). Under the
same conditions, however, HHV-8 glycoproteins recog-
nized by KS1 human sera were completely inhibited by
PAA (data not shown). These data suggested that the
continued synthesis of HHV-8 P50 depended on viral
DNA replication and hence belongs to the early–late
class of HHV-8 proteins. Furthermore, these data also
strengthened the HHV-8 specificity of Mab 11D1 and the
P50 protein it recognized.
Mab 11D1 against HHV-8 P50 recognizes a cDNA
encoding HHV-8 ORFs 59 and 58
To define further the virus specificity of HHV-8 P50 and
to identify the encoding gene(s), a cDNA library con-
structed from TPA-induced BCBL-1 cells was screened
with Mab 11D1. Two cDNA inserts of about 2.3 kb were
identified and the Mab did not react with phages without
insert or phages with inserts recognized by other Mabs
(data not shown). Sequence analysis showed that both
cDNAs were identical with one cDNA 16 bp longer at the
59 end than the other. Details of the longer cDNA (pCD50)
are given here (Fig. 3). The pCD50 cDNA is 2310 bp long
with a polyadenylation signal sequence (AATAAA) at nu-
cleotide positions 2281–2286 (Fig. 3C). This cDNA en-
codes two ORFs. The 59 ORF is in reading frame 3 with
an open 59 end and in frame with the 35 AA b-galacto-
sidase fusion partner in the lZAPII vector (Fig. 3C). The
first methionine is at nucleotide position 30, ends at
position 1220, and encodes a 396-AA-long ORF with a
calculated molecular weight of 42,382 (Fig. 3D). It is 100%
identical to the published HHV-8 ORF 59 sequence
(Russo et al., 1996; Neipel et al., 1997) (Figs. 3A and 3B).
The putative ORF 59 protein is highly hydrophilic, with
three potential sites for the addition of N-linked oligosac-
charides, but lacks membrane spanning signal or trans-
membrane sequences. There is a potential nuclear tar-
geting signal sequence (HKRR) at aa positions 371–374
and analysis by PSORT program predicted the ORF 59 as
a nuclear protein.
The second ORF is in reading frame 1 (position 1225 to
2298), 357 AA long, and encodes a highly hydrophobic
protein with a calculated molecular weight of 39,666 (Fig.
3D). This ORF is 100% identical to the published HHV-8
ORF 58 (Russo et al., 1996; Neipel et al., 1997) (Figs. 3A
and 3B). A cleavable N-terminal signal sequence and
several potential transmembrane regions were predicted
in the putative ORF 58. The PSORT program predicted
the putative ORF 58 protein as type IIIa or IIIb plasma
membrane associated protein. In order to express the
cDNA insert for Mab screening, it must be in frame with
the b-galactosidase fusion partner. Since ORF 59 is in
frame with the b-galactosidase fusion partner, we con-
cluded that Mab 11D1 recognized the ORF 59 protein.
HHV-8 P50 recognized by Mab 11D1 from the BCBL-1
cells and the ORF59 protein encoded by the cDNA
are identical
To clarify further the relationship of the 50-kDa protein
immunoprecipitated by Mab 11D1 from the BCBL-1 cells
with the ORFs encoded by the pCD50 cDNA, in vitro
transcription and translation experiments were per-
formed. No specific protein was translated in the sam-
ples with RNA transcribed from T7 promoter (antisense)
(Fig. 4A, lane 1) or with no RNA (Figs. 4A, lane 3, and 4B,
lane 1). In contrast, the RNA transcribed from the T3
promoter of pCD50 cDNA plasmid (sense strand) was
translated into a polypeptide with an apparent molecular
weight of 50 kDa (Fig. 4A, lane 2). In vitro translation of
transcripts from the ORF 59 alone in the pGEM-T vector
also resulted in the synthesis of a polypeptide of about
50 kDa (Fig. 4B, lane 2). This clearly demonstrated that
the ORF59 gene encodes the HHV-8 P50 protein. Staph-
ylococcus V8 protease was used in a partial peptide
mapping of the in vitro translated polypeptide and the
50-kDa polypeptide immunoprecipitated by the Mab
11D1 from TPA-induced BCBL-1 cells (Fig. 2A, lane 8).
Both polypeptides showed identical peptide profiles (Fig.
4C, lanes 1 and 2). We concluded that the protein rec-
ognized by Mab 11D1 from the TPA-induced BCBL-1 cells
and the ORF 59 protein encoded by the cDNA insert
pCD50 are identical. These results also clearly demon-
strated the HHV-8 specificity of the Mab 11D1. In prelim-
inary studies, we have generated a partial ORF59 (268
FIG. 3. Schematic representation of the cDNA insert identified by
Mab. The top line shows the schematic representation of HHV-8 long
unique region (LUR). (A and B) Location of the cDNA insert in the HHV-8
genome. The numbers indicate the nucleotide positions of ORFs 59
and 58 (Russo et al., 1996). The arrow indicates the direction of
transcription. (C and D) Location of the 2.3-kb cDNA encoding two
ORFs of 396AA (59 end) and 357AA (39 end) with an open 59 end. AAAA
represents the poly(A) tail.
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amino acids) in GST vector. Mab 11D1 recognized this
truncated protein in Western blots (data not shown). This
also demonstrated that the 50-kDa band was actually
derived from ORF 59.
HHV-8 ORF 59 cDNA is generated from an early–late
class transcript
To define further the viral specificity of 2.3 kb HHV-8
P50 cDNA insert (pCD50), total RNA was isolated from
uninduced and TPA-induced BCBL-1 cells and BJAB
cells. Two batches of cells were used in these experi-
ments. One was used for the radiolabeling experiments
as described in the legend to Fig. 2B and the other was
used for extracting RNA. Total RNAs were analyzed by
Northern blot hybridization with a 2.3-kb antisense RNA
probe transcribed from the pCD50 cDNA insert. No hy-
bridization was detected with total RNAs from uninduced
and TPA-induced BJAB (HHV-8-negative) cells (Fig. 5A,
lanes 1 and 2). Under conditions of high stringency, the
pCD50 RNA probe hybridized specifically to a prominent
2.3-kb transcript from uninduced and TPA-induced cells
(48 h p.i.) (Fig. 5A, lanes 3 and 4). Longer exposure of the
autoradiograph also revealed several additional RNAs
from uninduced and TPA-induced BCBL-1 cells (Figs. 5A,
lanes 3 and 4, and 5B, lanes 3–7) with the 2.3-kb RNA
species being most abundant (Figs. 5A and 5B). The
calculated sizes of the other RNA bands detected were
4.3 kb, 1.9 kb, 1.8 kb, 1.2-kb doublet (1.2 and 1.15), 1.0-kb
doublet (1.1 and 1.0), and 0.73 kb (Figs. 5A and 5B). To
confirm that an equal amount of RNA was loaded in each
sample and to verify the integrity of the RNA samples, the
membrane was stripped and then rehybridized with the
GAPDH probe, a cellular constitutive enzyme expressed
in all cells. No appreciable difference in the intensity of
GAPDH RNA was observed in samples from uninduced
and TPA-induced BCBL-1 and BJAB cells (Fig. 5A.).
To determine the kinetics of RNAs identified by HHV-8
pCD50 insert, RNA extracted from TPA-induced cells
collected at 24, 48, and 72 h p.i. was hybridized with the
antisense RNA probe transcribed from the pCD50 cDNA
insert (Fig. 5B). No hybridization was detected with total
RNA from uninduced and TPA-induced BJAB (HHV-8-
negative) cells (Fig. 5B, lanes 1 and 2). All the different
RNAs species hybridized with pCD50 probe could be
detected in both uninduced and TPA-induced cells (24 h
p.i.) (Fig. 5B, lanes 3 and 4). The 4.3-kb RNA band was
seen only after longer exposure of the autoradiograph.
The highest level of the abundant 2.3-kb message was
detected at 48 h p.i. (Fig. 5B, lane 6). However, the
synthesis of 2.3- and 1.9-kb RNAs was greatly reduced by
72 h p.i. (Fig. 5B, lane 7). In contrast, the synthesis of 1.8
kb and the 1.2- and 1.0-kb doublets remained unchanged
with an increase in the signal at the broad 0.7-kb band.
FIG. 5. (A, top) Identification of transcripts hybridized with the cDNA
insert. Total unfractionated RNA was isolated from uninduced and
TPA-induced BJAB (lanes 1 and 2) and from uninduced and TPA-
induced BCBL-1 cells (lanes 3 and 4). Samples were analyzed by
Northern blot hybridization with a radiolabeled, in vitro transcribed RNA
probe synthesized from the 2.3-kb cDNA insert in plasmid pCD50. (A,
bottom) Membrane from A, top, was stripped and probed with a radio-
labeled GAPDH RNA probe. The sizes (in kilobases) of the hybridized
RNAs are indicated. Standard RNA marker molecules of known sizes
were included in parallel lanes. (B) Kinetics of RNAs identified by
HHV-8 pCD50 insert. (Top) Total unfractionated RNA was isolated from
cells. Lane 1, uninduced BJAB; lane 2, TPA-induced BJAB cells; lane 3,
uninduced BCBL-1 cells; lane 4, BCBL-1 cells collected after 24 h of
TPA induction; lane 5, BCBL-1 cells collected after 24 h of PAA and TPA
treatment; lane 6, BCBL-1 cells collected after 48 h of TPA induction;
lane 7, BCBL-1 cells collected after 72 h of TPA induction. This autora-
diograph was exposed longer than the one shown in A. (Middle)
Membrane from B, top, was stripped and probed with a radiolabeled
GAPDH RNA probe. (Bottom) Membrane from the middle panel was
stripped and probed with a HHV-8 cDNA Riboprobe encoding a novel
HHV-8 glycoprotein K8.1 (B. Chandran et al., manuscript in preparation).
The sizes (in kilobases) of the hybridized RNAs are indicated. Standard
RNA marker molecules of known sizes were included in parallel lanes.
FIG. 4. (A) In vitro translation of RNA transcribed from the pCD50
cDNA insert. Sense and antisense transcripts prepared in vitro from the
cDNA insert were translated in vitro using rabbit reticulocyte lysates
and [35S]methionine. Lane 1, RNA transcribed from T7 promoter; lane 2,
RNA transcribed from T3 promoter; lane 3, translation without the
addition of RNA. (B) Translation of sense transcripts prepared from the
ORF59 insert alone in the pGEM-T vector. Lane 1, translation without
the addition of RNA; lane 2, RNA transcribed from SP6 promoter.
Samples were analyzed on 9% acrylamide cross-linked with N,N9-
diallyltartardiamide. (C) Product made from the pCD50 sense transcript
is identical to the HHV-8 P50 protein immunoprecipitated from HHV-8-
infected BCBL-1 cells. The [35S]methionine-labeled 50-kDa in vitro
translated polypeptide from A, lane 2, and the HHV-8 P50 immunopre-
cipitated from BCBL-1 cells from Fig. 2, lane 8, were separated by
SDS–PAGE, subjected to partial proteolysis using 10 mg of V8 protease,
and analyzed on 15% SDS–PAGE. Lane 1, P50 immunoprecipitated from
BCBL-1 cells; lane 2, 50-kDa in vitro translated polypeptide.
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This indicated differential regulation of the transcripts
from the HHV-8 ORF 59 gene locus.
To determine whether the HHV-8 pCD50 RNA species
belong to early or late class of transcripts expressed in a
lytic infection, TPA-induced BCBL-1 cells were incubated
with PAA for 24 h. At 24 h p.i., all the different pCD50 RNA
species could be detected in TPA-induced, PAA-treated
cells, but the intensity of the signal was much lower than
that of the untreated control (Fig. 5B, lane 4). When this
membrane was stripped and rehybridized with the
GAPDH riboprobe, no inhibition of the GAPDH RNA by
PAA was observed. In contrast, an RNA transcript de-
tected by a cDNA riboprobe encoding a novel HHV-8
glycoprotein K8.1 (B. Chandran et al., manuscript in prep-
aration) was completely inhibited by the PAA treatment
(Fig. 5B). The complete inhibition by PAA demonstrated
the glycoprotein transcript encoded a truly late class of
herpesvirus protein. On the contrary, the expression of all
the different pCD50 RNAs was significantly, but incom-
pletely, inhibited by PAA treatment. The incomplete inhi-
bition suggested that some transcription of the pCD50
locus can occur prior to viral DNA synthesis. Taken
together, all the RNA species in the HHV-8 gene locus
encoding ORFs 59 and 58 should be classified as early–
late transcripts.
DISCUSSION
In this report, we have identified and characterized the
HHV-8 protein P50 and the encoding cDNA specifically
recognized by Mab 11D1. It may be argued that this Mab
merely recognizes a host protein that is stimulated by
TPA. However, evidence such as (i) the nonreactivity of
this Mab with HHV-8-negative BCBL cells and other B
cell lines stimulated with TPA, (ii) the reactivity of Mab
with a 50-kDa protein from BCBL-1 cells and its synthe-
sis potentially related to viral DNA replication, (iii) the
recognition of a HHV-8-specific cDNA encoding a 59 ORF
identical to the genomic ORF 59, and (iv) the identical
partial peptide maps of HHV-8 P50 from BCBL-1 cells
and that of the protein (ORF59) encoded by pCD50
strongly demonstrated the HHV-8 specificity of Mab11D1.
This HHV-8 ORF 59-specific Mab 11D1 will be highly
useful in monitoring the lytic replicative cycle of HHV-8 in
KS tissues and other in vivo sites and such studies are in
progress.
Several studies suggest that the HHV-8-carrying BC-1,
HBL-6, BCP, and BCBL-1 cells are virus producer cells
and, in this respect, they resemble EBV producer cell
lines P3HR-1 and B95-8 (Kieff, 1996). About 3 to 8% of
uninduced BCBL-1 cells showed moderate cytoplasmic
fluorescence with sera from HHV-81 KS1 patients and
this reactivity was presumed to be reacting with the lytic
antigens (B. Chandran et al., manuscript in preparation;
Lennette et al., 1996; Smith et al., 1997). The number of
cells recognized by KS1 sera increased to 25–30% after
5 days post-TPA induction and such reactions were not
seen with HHV-8- and EBV-negative B cell lines. Simi-
larly, Mab 11D1 recognized about 3–8% of uninduced
BCBL-1 cells and 25–30% of TPA-induced cells. Further-
more, transcripts encoding lytic antigens were detected
in BCBL-1, BC-1, and HBL-6 cells albeit in lower quanti-
ties (Cesarman et al., 1996; Moore et al., 1996a,b). Hy-
bridization of HHV-8 P50 cDNA insert with all the specific
RNAs from uninduced BCBL-1 cells (Fig. 5), albeit in
lower quantity, further confirmed the notion that BCBL-1
cell is a producer cell line with a low percentage of
uninduced cells producing lytic cycle proteins.
HHV-8 ORF 59 gene is homologous to HSV-1 UL42,
HCMV UL44, HHV-6 U27, and EBV BMRF-1 genes (Russo
et al., 1996) encoding the lytic cycle associated early–
late class accessory proteins which are essential for
viral DNA replication (Ertl and Powell, 1992; Gottlieb and
Challberg, 1994; Leach and Mocarski, 1989; Oguro et al.,
1987; Pari et al., 1993; Pfitzner et al., 1987; Reddig et al.,
1994; Ripalti et al., 1995; Stasiak and Mocarski, 1992;
Zhou et al., 1994, 1997). The dependency of continued
synthesis of HHV-8 P50 on viral DNA replication as
shown in the PAA experiments (Figs. 2B and 5B) and the
hybridization of HHV-8 P50 cDNA insert with multiple
transcripts are traits that are also similar to HSV-1 UL42,
HCMV UL44, HHV-6 U27, and EBV BMRF-1 genes and
gene products. The synthesis of HHV-8 P50 protein at
this time point corresponds to its possible role as an
accessory protein for viral DNA replication. Further stud-
ies are required for analyzing the role of HHV-8 ORF 59
in the viral replication. The homologous protein in other
herpesviruses have been shown to be phosphoproteins
(Chang and Balachandran, 1991; Kieff, 1996). The sizes of
protein recognized by Mab 11D1 from infected cells and
the protein synthesized from the in vitro transcribed RNA
are slightly larger (50 kDa) than the predicted size of ORF
59 protein (about 43 kDa). Since Mab did not react with
[3H]glucosamine-labeled infected cells, the higher ap-
parent molecular weight in SDS–PAGE could be due to
posttranslational modification such as phosphorylation.
Herpesvirus accessory proteins have been shown to
be very important for viral replication and gene regula-
tion (Ertl and Powell, 1992; Gottlieb and Challberg, 1994;
Leach and Mocarski, 1989; Oguro et al., 1987; Pari et al.,
1993; Pfitzner et al., 1987; Reddig et al., 1994; Ripalti et al.,
1995; Stasiak and Mocarski, 1992; Zhou et al., 1994).
Gene expression of the accessory gene loci in these
viruses appears to be extremely complex. Multiple tran-
scripts have been detected in the herpes viral DNA
polymerase accessory protein gene locus and all of
these transcripts share 39 termini (Leach and Mocarski,
1989; Oguro et al., 1987; Pfitzner et al., 1987; Stasiak and
Mocarski, 1992; Zhou et al., 1997). Generally, three to six
nonspliced RNA species with different sizes were found
to initiate at different positions. The predominant me-
dium size RNA are the coding transcripts for accessory
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protein. The largest and smallest RNAs are minor spe-
cies and their functions are unclear. For example, for the
EBV BMRF1 locus, three different sizes of RNA (3.5, 2.7,
and 1.5 kb) were found to hybridize to the BMRF1 cDNA
which encode the 50-kDa EBV accessory protein (Oguro
et al., 1987; Pfitzner et al., 1987). In the HCMV UL44/
ICP36 locus, four RNA species of about 8.0, 4.8, 3.2, and
2.0 kb were detected by Northern hybridization (Leach
and Mocarski, 1989; Pari et al., 1993). We have reported
at least six different sizes of RNA species for HHV-6
accessory gene locus U27 (Zhou et al., 1997). Since all
the RNA species detected were polyadenylated and
polyribosome associated, they may be actively engaged
in protein synthesis (Zhou et al., 1997). Using primer
extension and S1 mapping techniques, the 59 and 39
ends of each HHV-6 U27 transcripts were mapped to
different positions and no splicing was observed (Zhou
et al., 1997). The present studies showed that at least
seven RNA species were transcribed from the HHV-8
ORFs 59 and 58 genes and the kinetic studies showed
that these RNAs should be classified as the early–late
gene products. Similar to HHV-8 pCD50 cDNA, a HHV-6
cDNA encoding two ORFs, has been identified by a
HHV-6 monoclonal antibody (Chang and Balachandran,
1991; Zhou et al., 1994). This cDNA is also open at the 59
end with the 59 ORF encoding the HHV-6 U27 and the
Mab used specifically recognized the ORF U27 protein
(Chang and Balachandran, 1991; Zhou et al., 1994).
Whether HHV-8 ORF 59 is also encoded by a monocis-
tronic message, the promoter for these RNAs and their
regulation need to be studied further. It appears that the
multiple transcriptional pattern in these gene loci may be
important for the viral gene regulation or expression.
Therefore, further investigation of the proteins encoded
by these HHV-8 RNAs is essential for the understanding
of the regulation, function(s), interaction with HHV-8 DNA
polymerase and role in viral DNA replication of this
putative DNA replication accessory protein and such
studies are in progress.
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